SGLT-2 drug plus moderate calorie restriction achieves higher diabetes remission: Study Dr. Kamal Kant Kohli23 Jan 2025 9:15 AM ISTAdults with overweight or obesity and type 2 diabetes who are given the sodium glucose cotransporter 2 (SGLT-2) inhibitor drug dapagliflozin alongside...
REFORM study: Reviewing Effects of Vildagliptin-Dapagliflozin FDC on HbA1c & Weight in Type 2 Diabetes Management MD Brand Connect17 Jan 2025 12:00 PM ISTThe fixed-dose combination (FDC) of Vildagliptin 100mg SR and Dapagliflozin 10mg showed significant glycemic control, weight reduction, and favorable...
Dapagliflozin and metformin combo well-tolerated and associated with decreased risk of adverse events: Study Dr. Shravani Dali17 Jan 2025 9:15 AM ISTA study published in Diabetes Research and Clinical Practice suggests that dapagliflozin and metformin are well-tolerated and associated with a...
Indian Pharma Market reaches Rs 19,083 crore in December, Check out top performing brands Farhat Nasim16 Jan 2025 7:43 PM ISTNew Delhi: The Indian Pharmaceutical Market (IPM) has experienced robust growth, reaching a market value of Rs 19,083 crore in December 2024. This...
Research Highlights Expanded Clinical Uses of SGLT2 Inhibitors Medha Baranwal6 Jan 2025 8:30 AM ISTUSA: A recent editorial published in the Journal of Cardiothoracic and Vascular Anesthesia highlights the growing clinical applications of...
Right Turn Show - Decoding the Use of Dapagliflozin and its Combinations with Metformin and Sitagliptin in Specialty Care Settings MD Brand Connect18 Dec 2024 12:00 PM ISTPresenting Episode 2 of the Right Turn Show, in this episode, insights from leading experts are explored on the practical application of dapagliflozin...
Delhi HC Upholds AstraZeneca's Tagrisso Patent, Imposes Rs 7L Fine on 'Habitual Infringer' for Knockoff Production Farhat Nasim2 Dec 2024 4:48 PM ISTNew Delhi: In a major relief to AstraZeneca, the Delhi High Court has granted summary judgment, confirming that Westcoast Pharmaceutical Works Ltd....
Right Turn Show - Optimal Use of Dapagliflozin and its Combinations in Specialty Care Settings MD Brand Connect30 Oct 2024 10:00 AM ISTBringing you the 'Right Turn Show,' where we focus on the optimal use of dapagliflozin and its combinations in speciality care settings. In this...
Dapagliflozin Glimepiride Metformin FDC in Uncontrolled T2DM with HbA1c >9 % Dr Rajeev Chawla8 Oct 2024 12:24 PM ISTIntroductionIndia has the second highest rate of diabetes in the world. (1) According to the ICMR-INDIAB-17 study, the prevalence of diabetes in India...
Early Dapagliflozin Administration Cuts Heart Failure Admissions, Study Finds Dr. Prem Aggarwal3 Oct 2024 9:00 AM ISTJapan: A recent study has shed light on the effects of early versus late administration of dapagliflozin in patients suffering from decompensated...
Triple Therapy: GEMI + DAPA Enhances Glycemic Control for Type 2 Diabetics on Metformin, SOLUTION 2 study Medha Baranwal3 Oct 2024 8:00 AM ISTSouth Korea: Gemigliptin and dapagliflozin dual add-on therapy (GEMI+DAPA) along with metformin is safe, effective, and well-tolerated, particularly...
Eris Lifscience Gets CDSCO Panel Nod To Manufacture, Market Antidiabetic FDC Dr. Divya Colin29 Sept 2024 6:00 PM ISTNew Delhi: Reviewing the bioequivalence (BE) study report of the fixed-dose combination (FDC) antidiabetic drug Dapagliflozin Propanediol Monohydrate...
